share_log

天士力(600535.SH):子公司获得药品注册证书

Tasly Pharmaceutical Group (600535.SH): Subsidiary obtains pharmaceutical registration certificate.

Gelonghui Finance ·  Dec 4, 2024 15:37

On December 4th, Tasly Pharmaceutical Group (600535.SH) announced that its wholly-owned subsidiary Jiangsu Tasly Pharmaceuticals Co., Ltd. (referred to as "Jiangsu Diyi") received the "Pharmaceutical Registration Certificate" approved and issued by the National Medical Products Administration for Paracetamol Oral Solution. According to the product instructions, Paracetamol Oral Solution is indicated for severe but reversible muscle spasms caused by multiple sclerosis, and may have certain efficacy on spasms caused by infectious, degenerative, traumatic, tumorous, or spinal diseases of unknown etiology.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment